BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 333044)

  • 1. Mechanisms of platelet shape change, aggregation, and release induced by collagen, thrombin, or A23,187.
    Kinlough-Rathbone RL; Packham MA; Reimers HJ; Cazenave JP; Mustard JF
    J Lab Clin Med; 1977 Oct; 90(4):707-19. PubMed ID: 333044
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo functions of thrombin-treated platelets.
    Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
    Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
    Smith JB; Ingerman CM; Silver MJ
    J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tris on responses of human and rabbit platelets to aggregating agents.
    Packham MA; Guccione MA; Nina M; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1984 Apr; 51(2):140-4. PubMed ID: 6429880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of heparin on platelet aggregation in vitro].
    RĂ³ka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathways responsible for platelet hypersensitivity in rats with diabetes. II. Spontaneous diabetes in BB Wistar rats.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):154-8. PubMed ID: 3080539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone potentiation of ionophore and ADP induced platelet aggregation: relationship to arachidonic acid metabolism.
    Pilo R; Aharony D; Raz A
    Thromb Haemost; 1981 Aug; 46(2):538-42. PubMed ID: 6795741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin, collagen and A23187 stimulated endogenous platelet arachidonate metabolism: differential inhibition by PGE1, local anesthetics and a serine-protease inhibitor.
    Feinstein MB; Becker EL; Fraser C
    Prostaglandins; 1977; 14(6):1075-93. PubMed ID: 341226
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of prostaglandins in the ADP-induced aggregation of rabbit platelets shown by the use of 15-hydroxyprostaglandin dehydrogenase.
    Wallis RB
    Thromb Haemost; 1978 Jun; 39(3):725-32. PubMed ID: 705701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected effects of aurin tricarboxylic acid on human platelets.
    Kinlough-Rathbone RL; Packham MA
    Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylbutazone inhibition of equine platelet function.
    Meyers KM; Lindner C; Katz J; Grant B
    Am J Vet Res; 1979 Feb; 40(2):265-70. PubMed ID: 464364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergism between platelet aggregating agents: the role of the arachidonate pathway.
    Kinlough-Rathbone RL; Packham MA; Mustard JF
    Thromb Res; 1977 Nov; 11(5):567-80. PubMed ID: 337565
    [No Abstract]   [Full Text] [Related]  

  • 14. Properties of washed human platelets.
    Kinlough-Rathbone RL; Mustard JF; Packham MA; Perry DW; Reimers HJ; Cazenave JP
    Thromb Haemost; 1977 Apr; 37(2):291-308. PubMed ID: 327607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG; Littleton JM
    Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquisition and aggregation of canine blood platelets: basic mechanisms of function and differences because of breed origin.
    Clemmons RM; Meyers KM
    Am J Vet Res; 1984 Jan; 45(1):137-44. PubMed ID: 6422804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of platelet aggregation by a new agent, Ticlopidine.
    Ashida SI; Abiko Y
    Thromb Haemost; 1979 Feb; 40(3):542-50. PubMed ID: 425067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposite effect of lysine on platelet aggregation induced by arachidonate and by other aggregants.
    Ts'ao C; Hart SJ; Krajewski DV; Sorensen PG
    Thromb Haemost; 1982 Aug; 48(1):78-83. PubMed ID: 6813998
    [No Abstract]   [Full Text] [Related]  

  • 19. Clq inhibition of the interaction of collagen with human platelets.
    Cazenave JP; Assimeh SN; Painter RH; Pachham MA; Mustard JF
    J Immunol; 1976 Jan; 116(1):162-3. PubMed ID: 1245737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of equine platelet function by diethylcarbamazine (DEC).
    Kowalski KA; McConnell LA; Sadoff DA; Leid RW
    Am J Pathol; 1983 Oct; 113(1):1-7. PubMed ID: 6414306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.